ADMA Biologics
ADMA
ADMA
74 hedge funds and large institutions have $130M invested in ADMA Biologics in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less call options, than puts
Call options by funds: $107K | Put options by funds: $128K
22% less capital invested
Capital invested by funds: $165M → $130M (-$35.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
74
Holding in Top 10
–
Calls
$107K
Puts
$128K
Top Buyers
| 1 | +$3.3M | |
| 2 | +$2.16M | |
| 3 | +$900K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$588K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$580K |
Top Sellers
| 1 | -$2.9M | |
| 2 | -$2.44M | |
| 3 | -$2.38M | |
| 4 |
BC
Broadfin Capital
New York
|
-$2.25M |
| 5 |
JG
Jefferies Group
New York
|
-$2.23M |